期刊文献+

野生型PTEN基因重组腺病毒表达载体构建的改进及其鉴定

Improvement of construction of wild-type PTEN gene recombinant adenovirus expression vector and its identification
下载PDF
导出
摘要 目的为改进构建野生型抑癌基因PTEN重组腺病毒表达载体的方法。方法用抑癌基因PTEN与带有绿色荧光蛋白基因的穿梭载体pAdTrack-CMV重组后转化含腺病毒骨架载体pAdEasy1的E.coliBJ5183(Ad-1 cells),以获得重组腺病毒质粒,经限制酶PacⅠ线性化后,转染293细胞,检测PTEN蛋白的表达,并以Ad-PTEN感染人乳腺癌MCF-7细胞后,测其感染率。结果获得PTEN基因的重组腺病毒表达载体(Ad-PTEN),受Ad-PTEN转染的293细胞发生肿胀或圆缩的形态改变,经PCR对传代的Ad-PTEN分析证实得到目的基因PTEN,荧光显微镜下能观察到293细胞内有绿色荧光。通过Western blot可检测到293细胞中PTEN蛋白高效表达。Ad-PTEN感染的人乳腺癌MCF-7细胞,感染率达80%-90%。结论PTEN重组腺病毒表达载体可在细菌体内进行同源重组而构建,方法较简便、快速,且生成的病毒滴度高、感染率高。 Objective To improve the construction of adenovirus expression vector harbouring wide-type tumor suppressor gene PTEN. Methods PTEN gene was inserted into the shuttle vector pAdTrack-CMV containing green fluorescence protein (GFP) gene, the recombinant plasmid containing adenovirus backbone vector pAdEasy-1 was then transformed into E. coli (BJ5183). PTEN protein expression in the recombinant was determined after Pac I linearization and 293 cell transfection, and its infection rate was detected by human breast cancer cell line MCF-7 infection. Results Recombinant adenovirus expression vector Ad-PTEN was obtained. The transfected 293 cells showed cytopathic effect. PTEN gene and protein expression and green fluorescence were observed in passage 293 cells. The infection rate of MCF-7 cells was 80 % --90 %. Conclusion Recombinant adenovirus expression vector Ad-PTEN can be constructed by homologous recombination with bacteria. The construction method is simple and rapid, and Ad-PTEN infection test exhibits high virus titer and infection rate.
出处 《广东医学院学报》 2008年第2期115-119,共5页 Journal of Guangdong Medical College
基金 广东省重点学科建设资助项目(编号:GX9307)
关键词 重组腺病毒 PTEN 基因治疗 recombinant adenovirus PTEN gene therapy
  • 相关文献

参考文献11

  • 1Majhen D, Ambriovi'c-Ristov A. Adenoviral vectors-how to use them in cancer gene therapy? [J]. Virus Res,2006, 119 (2) :121-133.
  • 2He T C, Zhou S, Costada L T, et al. A simplified system for generating recombinant adenoviruses[J]. Proc Natl Acad Sci USA, 1998, 9(5) :2509-2514.
  • 3Cristofano A D, Pandolfi P P. The multiple roles of PTEN in tumor suppression[J ]. Cell, 2000,100(4) :387-390.
  • 4Knobbe C B, Merlo A, Reifenberger G. PTEN signaling in gliomas[J]. Neuro Oncol,2002,4(3) : 196-211.
  • 5Deocampo N D, Huang H, Tindall D J. The role of PTEN in the progression and survival of prostate cancer [J ]. Minerva Endocrinol, 2003, 28(2) :145-153.
  • 6Cheney I W,Johnson D E, Vaillancourt M T, et al. Suppression of tumorigenicity of glioblastoma cells by adenovirus-mediated MMAC1/PTEN gene transfer [J]. Cancer Res, 1998, 58 (11): 2331-2334.
  • 7Furnari F B, Huang H J, Cavenee W K. The phosphoinositol phosphatase activity of PTEN mediates a serum-sensitive G1 growth arrest in glioma cells [J]. Cancer Res, 1998, 58(22) : 5002-5008.
  • 8Musatov S, Roberts J, Brooks A I, et al. Inhibition of neuronal phenotype by PTEN in PC12 cells [J]. Proc Natl Acad Sci USA, 2004, 101(10):3627-3631.
  • 9Weng L P, Gimm O, Kum J B, et al. Transient ectopic expression of PTEN in thyroid cancer cell lines induces cell cycle arrest and cell type-dependent call death [J ]. Hum Mol Genet, 2001,10 (3): 251-258.
  • 10Bert AJ, Haddara W, Prevec L, et al. An efficient and flexible system for construction of adenovirus vectors with insertions or deletions in early regions 1 and 3 [J]. Proc Natl Acad Sci USA, 1994, 91(19) :8802-8806.

二级参考文献8

  • 1Li J;Yen C;Liaw D.PTEN,a putative protein tyrosine phosphatase gene mutated in human brain,breast,and prostate cancer[J],1997(5308).
  • 2Li DM;Sun H.TEP1,encoded by a candidate tumor suppressor locus,is a novel protein tyrosine phosphatase regulated by transforming growth factor beta,1997(11).
  • 3Greenlee RT;Murray T;Bolden S;Wingo PA.Cancer statistics, ,2000[J],2000(1).
  • 4Steck PA;Pershouse MA;Jasser SA.Identification of a candidate tumour suppressor gene,MMAC1,at chromosome 10q23.3 that is mutated in multiple advanced cancers[J],1997.
  • 5irns P;Okami K;Halachmi S.Frequent inactivation of PTEN/MMAC1 in primary prostate cancer,1997.
  • 6Suzuki H;Freije D;Nusskern DR.Interfocal heterogeneity of PTEN/MMAC1 gene alterations in multiple metastatic prostate cancer tissues[J],1998.
  • 7Dong JT;Li CL;Sipe TW.Mutations of PTEN/MMAC1 in primary prostate cancers from Chinese patients[J],2001.
  • 8Mizuguchi H;Hayakawa T.Characteristics of adenovirus-mediated tetracycline-controllable expression system[J],2001.

共引文献4

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部